In BTBR ob/ob mice, the combination of dapagliflozin with ticagrelor (P2Y12 receptor antagonist) also reduces cardiac hypertrophy, apoptosis, inflammation, fibrosis, and NLRP3 inflammasome markers associated with DCM (29). The gene discussed is NLRP3; the disease is familial dilated cardiomyopathy.